by upagency | Feb 28, 2021 | Press Releases
On International Rare Diseases Day, we’d like to introduce 2N Pharma’s approach to finding treatments for #ALS and other neurodegenerative disorders. Amyotrophic Lateral Sclerosis (ALS), also known as Lou Gehrig’s Disease or Motor Neurone Disease (MND) is a rapidly...
by upagency | Feb 24, 2021 | Press Releases
On the International Day of Women and Girls in Science, Anne Skøttrup Mørkholt, 2N Pharma’s Project Manager talked about her career to date in bio-pharmacology and her role in the search for cures to incurable diseases. What was it that made you...
Recent Comments